Literature DB >> 17851628

B-natriuretic peptide: a helpful clinical marker after Norwood I.

William N Evans1, Ruben J Acherman, Gary A Mayman, Abraham Rothman.   

Abstract

Amplified cardiac B-natriuretic peptide (BNP) expression results from ventricular volume or pressure overload. Clinicians have used BNP levels when evaluating cardiac performance in patients with varied clinical conditions. We report a case in which BNP levels helped guide early catheterization intervention in a patient after stage 1 Norwood palliation.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17851628     DOI： 10.1007/s00246-007-9078-y

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  11 in total

Review 1.  Regulation of natriuretic peptide secretion by the heart.

Authors:  G Thibault; F Amiri; R Garcia
Journal:  Annu Rev Physiol       Date:  1999       Impact factor: 19.318

2.  First-stage palliation for hypoplastic left heart syndrome in the twenty-first century.

Authors:  Jeffrey M Pearl; David P Nelson; Steven M Schwartz; Peter B Manning
Journal:  Ann Thorac Surg       Date:  2002-01       Impact factor: 4.330

3.  Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction.

Authors:  A S Maisel; J Koon; P Krishnaswamy; R Kazenegra; P Clopton; N Gardetto; R Morrisey; A Garcia; A Chiu; A De Maria
Journal:  Am Heart J       Date:  2001-03       Impact factor: 4.749

4.  Comparison of hemodynamics between Norwood procedure and systemic-to-pulmonary artery shunt for single right ventricle patients.

Authors:  Shin Takabayashi; Hideaki Kado; Yuichi Shiokawa; Kouji Fukae; Toshihide Nakano
Journal:  Eur J Cardiothorac Surg       Date:  2005-04-09       Impact factor: 4.191

5.  Evolving strategies and improving outcomes of the modified norwood procedure: a 10-year single-institution experience.

Authors:  T Azakie; S L Merklinger; B W McCrindle; G S Van Arsdell; K J Lee; L N Benson; J G Coles; W G Williams
Journal:  Ann Thorac Surg       Date:  2001-10       Impact factor: 4.330

6.  Normal values of B type natriuretic peptide in infants, children, and adolescents.

Authors:  A Koch; H Singer
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

7.  Home surveillance program prevents interstage mortality after the Norwood procedure.

Authors:  N S Ghanayem; G M Hoffman; K A Mussatto; J R Cava; P C Frommelt; N A Rudd; M M Steltzer; S M Bevandic; S S Frisbee; R D B Jaquiss; S B Litwin; J S Tweddell
Journal:  J Thorac Cardiovasc Surg       Date:  2003-11       Impact factor: 5.209

8.  Outcomes after the Norwood operation in neonates with critical aortic stenosis or aortic valve atresia.

Authors:  David A Ashburn; Brian W McCrindle; Christo I Tchervenkov; Marshall L Jacobs; Gary K Lofland; Edward L Bove; Thomas L Spray; William G Williams; Eugene H Blackstone
Journal:  J Thorac Cardiovasc Surg       Date:  2003-05       Impact factor: 5.209

9.  Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress.

Authors:  S Koulouri; R J Acherman; P C Wong; L S Chan; A B Lewis
Journal:  Pediatr Cardiol       Date:  2004 Jul-Aug       Impact factor: 1.655

Review 10.  Guidelines for the outpatient management of complex congenital heart disease.

Authors:  Gil Wernovsky; Jonathan J Rome; Sarah Tabbutt; Jack Rychik; Meryl S Cohen; Stephen M Paridon; Gary Webb; Kathryn M Dodds; Maureen A Gallagher; Desiree A Fleck; Thomas L Spray; Victoria L Vetter; Marie M Gleason
Journal:  Congenit Heart Dis       Date:  2006-01       Impact factor: 2.007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.